UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations

PLoS pathogens, 2019-08, Vol.15 (8), p.e1007991-e1007991

2019

Volltextzugriff (PDF)

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

Clinical infectious diseases, 2015-08, Vol.61 (3), p.403-408

2015

Volltextzugriff (PDF)

Impact of very early antiretroviral therapy during acute HIV infection on long-term immunovirological outcomes

International journal of infectious diseases, 2023-11, Vol.136, p.100-106

2023

Volltextzugriff (PDF)

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

Infectious diseases and therapy, 2024-03, Vol.13 (3), p.609-617

2024

Volltextzugriff (PDF)

Farmacología de Symtuza® (DRV/c/FTC/TAF)

Enfermedades infecciosas y microbiología clínica, 2018-12, Vol.36, p.10-16

2018

Volltextzugriff (PDF)

Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

Journal of cancer research and clinical oncology, 2023-12, Vol.149 (20), p.18161-18171

2023

Volltextzugriff (PDF)

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health

Journal of Virus Eradication, 2018-07, Vol.4 (3), p.196-207

2018

Volltextzugriff (PDF)

A risk assessment tool for predicting fragility fractures in people with HIV: derivation and internal validation of the FRESIA model

Journal of bone and mineral research, 2023-10, Vol.38 (10), p.1443-1452

2023

Volltextzugriff (PDF)

Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV

HIV medicine, 2023-06, Vol.24 (6), p.727-737

2023

Volltextzugriff (PDF)

Early diagnosis of anal intraepithelial neoplasia associated with human papillomavirus. What is the best strategy?

Enfermedades infecciosas y microbiologia clinica, 2016-08, Vol.34 (7), p.397

2016

Volltextzugriff (PDF)

From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir

Expert opinion on drug safety, 2011-05, Vol.10 (3), p.389-406

2011

Volltextzugriff (PDF)

HIV medical care interruption among people living with HIV in Spain, 2004-2020

AIDS (London), 2023-07, Vol.37 (8), p.1277-1284

2023

Volltextzugriff (PDF)

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

Current HIV research, 2009-11, Vol.7 (6), p.597-600

2009

Volltextzugriff (PDF)

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

The Journal of infectious diseases, 2023-10, Vol.228 (7), p.919-925

2023

Volltextzugriff (PDF)

Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain

The American journal of tropical medicine and hygiene, 2013-06, Vol.88 (6), p.1196-1202

2013

Volltextzugriff (PDF)

Recommendations for the early diagnosis of suspected human immunodeficiency virus infection in the emergency department and the referral of patients for follow-up: a consensus statement of the Spanish Society of Emergency Medicine (SEMES)

Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, 2020-12, Vol.32 (6), p.416

2020

Volltextzugriff (PDF)

Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with Cobicistat

AIDS reviews, 2015-04, Vol.17 (2), p.114-120

2015

Volltextzugriff (PDF)

Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease

Journal of antimicrobial chemotherapy, 2022-06, Vol.77 (7), p.1989-1991

2022

Volltextzugriff (PDF)

Chems4EU: chemsex use and its impacts across four European countries in HIV‐positive men who have sex with men attending HIV services

HIV medicine, 2021-11, Vol.22 (10), p.944-957

2021

Volltextzugriff (PDF)

Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus

Pharmacotherapy, 2019-04, Vol.39 (4), p.501-507

2019

Volltextzugriff (PDF)

Major cardiovascular events after COVID-19 in people with HIV

Clinical microbiology and infection, 2024-05, Vol.30 (5), p.674-681

2024

Volltextzugriff (PDF)

Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study

Journal of the American College of Cardiology, 2020-05, Vol.75 (20), p.2570-2584

2020

Volltextzugriff (PDF)

Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients

Journal of antimicrobial chemotherapy, 2018-03, Vol.73 (3), p.732-737

2018

Volltextzugriff (PDF)

Incidence of Anal Cancer and Related Risk Factors in HIV-Infected Patients Enrolled in the National Prospective Spanish Cohort CoRIS

Diseases of the colon & rectum, 2023-12

2023

Volltextzugriff (PDF)

HIV and TB coinfection: using adjusted doses of lopinavir/ritonavir with rifampin

Expert review of anti-infective therapy, 2011-12, Vol.9 (12), p.1115-1118

2011

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(131)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(166)
Spanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

Impact of very early antiretroviral therapy during acute HIV infection on long-term immunovirological outcomes

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

Farmacología de Symtuza® (DRV/c/FTC/TAF)

Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health

A risk assessment tool for predicting fragility fractures in people with HIV: derivation and internal validation of the FRESIA model

Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV

Early diagnosis of anal intraepithelial neoplasia associated with human papillomavirus. What is the best strategy?

From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir

HIV medical care interruption among people living with HIV in Spain, 2004-2020

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain

Recommendations for the early diagnosis of suspected human immunodeficiency virus infection in the emergency department and the referral of patients for follow-up: a consensus statement of the Spanish Society of Emergency Medicine (SEMES)

Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with Cobicistat

Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease

Chems4EU: chemsex use and its impacts across four European countries in HIV‐positive men who have sex with men attending HIV services

Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus

Major cardiovascular events after COVID-19 in people with HIV

Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study

Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients

Incidence of Anal Cancer and Related Risk Factors in HIV-Infected Patients Enrolled in the National Prospective Spanish Cohort CoRIS

HIV and TB coinfection: using adjusted doses of lopinavir/ritonavir with rifampin

Suchergebnisse filtern